Chronomodulated Administration of Oxaliplatin plus Capecitabine (XELOX) as First Line Chemotherapy in Metastatic Colorectal Cancer Patients: Phase II Brunch Regimen Study.

Kezban Nur Pilanci,Sezer Saglam,Alper Okyar,Serap Yucel,Zeliha Pala-Kara,Cetin Ordu,Esat Namal,Rumeysa Ciftci,Ülkühan İner Köksal,Esra Kaytan Saglam

Chronomodulated Administration of Oxaliplatin plus Capecitabine (XELOX) as First Line Chemotherapy in Metastatic Colorectal Cancer Patients: Phase II Brunch Regimen Study.

2015

Kezban Nur Pilanci
Sezer Saglam
Alper Okyar
Serap Yucel
Zeliha Pala-Kara
Cetin Ordu
Esat Namal
Rumeysa Ciftci
Ülkühan İner Köksal
Esra Kaytan Saglam

e14646 Background: The aim of this study was to evaluate efficacy and safety of chronomodulated capecitabine administered morning and noon according to a specific time schedule (Brunch Regimen: Bre...

Keywords:

Regimen
Capecitabine
Colorectal cancer
Oncology
Oxaliplatin
Chemotherapy
Medicine
Internal medicine
Morning
first line chemotherapy
specific time

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations